AQST — Aquestive Therapeutics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1398733 ·
Last close
$3.70
Market Cap
$465.04M
52W High
$6.74
52W Low
$2.93
ADV30
2,489,512
Next earnings
2026-11-03

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 7,557,000 3,951,000 -14,469,000 -16,496,000 119,327,000 90,349,000 190,151,000
Jun 2026 13,819,000 9,802,000 -8,223,000 -22,864,000 132,104,000 98,490,000 188,690,000
Mar 2026 14,446,000 10,977,000 -4,204,000 -8,057,000 141,125,000 110,734,000 175,179,000
Dec 2025 13,015,000 7,179,000 -28,839,000 -31,860,000 160,425,000 121,169,000 194,087,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-39,762,000
Investing CF
$-933,000
Financing CF
$1,981,000
CapEx
$-933,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.64
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-494,415,000
Inventory
$7,309,000
Receivables
$5,254,000
ST Investments
—
EBIT TTM
$-64,348,000
Pretax Income TTM
$-79,277,000
Interest Exp TTM
$14,929,000
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$48,837,000
EBITDA
$-55,174,000
Free Cash Flow
$-22,574,000
Enterprise Value
$422,155,616
Total Cash
$90,349,000
Total Debt
$58,772,000
Shares Out
125,687,705
Trailing EPS
$-0.65
Book Value
$-0.56
ROE
—
ROA
-24.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 44,545,000 -71,051,000 -83,784,000 160,425,000 194,087,000 -33,662,000 -52,432,000
Dec 2024 57,561,000 -30,771,000 -44,137,000 101,424,000 161,580,000 -60,156,000 -35,759,000
Dec 2023 50,583,000 -15,102,000 -7,870,000 57,418,000 163,905,000 -106,487,000 -6,380,000
Dec 2022 47,680,000 -42,066,000 -54,410,000 57,070,000 175,624,000 -118,554,000 -9,819,000

TTM Snapshot

Revenues TTM
$54,087,000
NetIncome TTM
$-78,227,000
OpCashFlow TTM
—
Assets (Latest)
$132,104,000
Forward EPS
$-0.50

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $3.00 · spot: $3.78 · call volume: 60 · put volume: 6,278
Expected Move to 2026-12-18: ±$0.60 (15.87%) — implied range $3.18 – $4.38 · ATM straddle on $4.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
STTK Shattuck Labs, Inc. $467.46M $4.59 —
ASMB ASSEMBLY BIOSCIENCES, INC. $460.74M $22.50 —
KMDA KAMADA LTD $470.92M $8.16 —
AMRN AMARIN CORP PLC\UK $473.82M $11.27 —
NGNE Neurogene Inc. $478.19M $23.10 —

News headlines (Yahoo Finance, 1h cache)

Aquestive Therapeutics to Present at the Piper Sandler 38th Annual Healthcare Conference
2026-11-18 12:00 · Yahoo
Aquestive Therapeutics to Present at the Jefferies Global Healthcare Conference
2026-11-09 12:00 · Yahoo
Aquestive Therapeutics Inc (AQST) (Q3 2026) Earnings Call Highlights: Revenue Dip Masks Anifilm ...
2026-11-06 19:05 · Yahoo
Aquestive Therapeutics to Present Data at the 2026 ACAAI Annual Meeting
2026-11-05 12:00 · Yahoo
Aquestive Therapeutics, Inc. Q3 2026 Earnings Call Summary
2026-11-04 17:57 · Yahoo
Aquestive (AQST) Q3 2026 Earnings Call Transcript
2026-11-04 17:05 · Yahoo
What Aquestive Therapeutics (AQST) Said on Its Q3 Earnings Call
2026-11-04 16:14 · Yahoo
Aquestive Therapeutics (AQST) Reports Q3 Loss, Misses Revenue Estimates
2026-11-03 21:15 · Yahoo
Aquestive Therapeutics: Q3 Earnings Snapshot
2026-11-03 21:14 · Yahoo
Aquestive Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-03 21:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.